Protective effect of losartan on endothelial cells exposed to high glucose levels in vitro.
- Author:
Yi-ping LI
1
;
Ying-nan WANG
;
Hong DENG
;
Ning SU
Author Information
- Publication Type:Journal Article
- MeSH: Angiotensin II Type 1 Receptor Blockers; pharmacology; Cells, Cultured; Endothelium, Vascular; cytology; metabolism; Glucose; pharmacology; Humans; Losartan; pharmacology; Peroxidase; metabolism; RNA, Messenger; biosynthesis; genetics; Superoxide Dismutase; metabolism; Umbilical Veins; cytology; Vascular Endothelial Growth Factors; biosynthesis; genetics
- From: Journal of Zhejiang University. Medical sciences 2006;35(3):238-244
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of losartan (an angiotensin II type I receptor antagonist) on endothelial cells exposed to high glucose in vitro and related mechanism.
METHODSVascular endothelial cells of human umbilical vein were cultured in media with high glucose levels. The activities of SOD and CAT, the level of MDA were measured by spectrophotometry in the conditioned media of endothelial cells, the VEGF mRNA expression was performed using semi-quantitative reverse transcription PCR (RT-PCR) in the cell lysates, and the protein expression of VEGF was examined by enzyme-linked immunosorbent assay (ELISA) in the supernatants of cultured cells.
RESULTWhen endothelial cells were cultured in high glucose, the activities of SOD and CAT were significantly decreased, but the level of MDA was markedly increased. However, the high glucose-induced effects were inhibited by losartan. The application of high glucose upregulated the mRNA and protein expression of VEGF in endothelial cells, which was also attenuated by losartan.
CONCLUSIONHigh glucose disrupts the oxidative equilibrium and increases the expression of VEGF in endothelial cells, which can be inhibited by losartan.